Naveen Pemmaraju, Director of Leukemia-Cancer Network, Executive Director of Cancer Medicine, Director of BPDCN at the Department of Leukemia, and Professor at the Department of Leukemia at MD Anderson Cancer Center, shared a post on X about a paper he co-authored with colleagues published in Leukemia and Lymphoma:
“Our multi-center report, our latest BPDCN collaborative network paper, is now out in L&L, as we aim to continue to raise awareness for our Rare Disease field!”
Title: Durable post-transplant survival after first-line tagraxofusp for blastic plasmacytoid dendritic cell neoplasm
Authors: Naveen Pemmaraju, Marina Konopleva, Muzaffar Qazilbash, Anthony S. Stein, David A. Rizzieri, Eunice S. Wang, Sumithira Vasu, Ira Gupta, Andrew A. Lane
You can read the Full Article in Leukemia and Lymphoma.
More posts featuring Naveen Pemmaraju.